109 related articles for article (PubMed ID: 19211071)
1. [Evaluation of the quality of life of patients with localizad prostate cancer: validation of the Spanish version of the EPIC].
Ferrer M; Garin O; Pera J; Prats JM; Mendivil J; Alonso J; De Paula B; Herruzo I; Hervas A; Macias V; Mariño A; Ortiz MJ; Pastor S; Ponce De León J; Sancho G;
Med Clin (Barc); 2009 Feb; 132(4):128-35. PubMed ID: 19211071
[TBL] [Abstract][Full Text] [Related]
2. [Quality of life in patients with prostate cancer: validation of an instrument for clinical practice].
Balbontín F; Marchetti P; Moreno S; Cabello JM; Urzúa C; Silva A; Avilés J; Badínez L; García J; Salgado A; Vinez E; Alliende I; Canals A; Velasco A
Arch Esp Urol; 2015 Jun; 68(5):466-73. PubMed ID: 26102050
[TBL] [Abstract][Full Text] [Related]
3. Cross-cultural adaptation and validation of the French version of the Expanded Prostate cancer Index Composite questionnaire for health-related quality of life in prostate cancer patients.
Anota A; Mariet AS; Maingon P; Joly F; Bosset JF; Guizard AV; Bittard H; Velten M; Mercier M
Health Qual Life Outcomes; 2016 Dec; 14(1):168. PubMed ID: 27923377
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life in men with localized prostate cancer treated with radiotherapy: validation of an abbreviated version of the Expanded Prostate Cancer Index Composite for Clinical Practice in Spain.
Zapatero A; Maldonado Pijoan X; Gómez-Caamaño A; Pardo Masferrer J; Macías Hernández V; Hervás Morón A; Muñoz García JL; Palacios Eito A; Anguita-Alonso P; González-Junco C; López Torrecilla J
Health Qual Life Outcomes; 2021 Sep; 19(1):223. PubMed ID: 34563208
[TBL] [Abstract][Full Text] [Related]
5. The German version of the Expanded Prostate Cancer Index Composite (EPIC): translation, validation and minimal important difference estimation.
Umbehr MH; Bachmann LM; Poyet C; Hammerer P; Steurer J; Puhan MA; Frei A
Health Qual Life Outcomes; 2018 Feb; 16(1):36. PubMed ID: 29458434
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer.
Wei JT; Dunn RL; Litwin MS; Sandler HM; Sanda MG
Urology; 2000 Dec; 56(6):899-905. PubMed ID: 11113727
[TBL] [Abstract][Full Text] [Related]
8. Psychometric validation of the Spanish version of the Expanded Prostate Cancer Index Composite-26.
Zamora V; Garin O; Suárez JF; Jové J; Castells M; Ferrer F; Gutiérrez C; Guedea F; Boladeras A; Fumadó L; Roselló A; Pastor J; Samper P; Pont À; Ferrer M
World J Urol; 2023 Dec; 41(12):3511-3518. PubMed ID: 37947846
[TBL] [Abstract][Full Text] [Related]
9. Validation of the Italian version of the abbreviated expanded prostate Cancer index composite (EPIC-26) in men with prostate Cancer.
Marzorati C; Monzani D; Mazzocco K; Masiero M; Pavan F; Monturano M; Pravettoni G
Health Qual Life Outcomes; 2019 Aug; 17(1):147. PubMed ID: 31464649
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors.
Szymanski KM; Wei JT; Dunn RL; Sanda MG
Urology; 2010 Nov; 76(5):1245-50. PubMed ID: 20350762
[TBL] [Abstract][Full Text] [Related]
11. Cross validation of the prostate cancer radiotherapy late toxicity (PCRT) questionnaire with the expanded prostate cancer index composite (EPIC) instrument.
Rodrigues G; Bauman G; Venkatesan V; Ahmad B; Lock M; Sexton T; D'Souza D; Stitt L; Eid S
Can J Urol; 2011 Aug; 18(4):5802-10. PubMed ID: 21854712
[TBL] [Abstract][Full Text] [Related]
12. Adaptation and validation of the Spanish version of the Patient-Oriented Prostate Utility Scale (PORPUS).
Avila M; Pardo Y; Castells M; Ferrer F; Boladeras A; Pera J; Prada PJ; Guix B; de Paula B; Hernandez H; Pont A; Alonso J; Garin O; Bremner K; Krahn M; Ferrer M;
Qual Life Res; 2014 Nov; 23(9):2481-7. PubMed ID: 24789667
[TBL] [Abstract][Full Text] [Related]
13. Validation of the Brazilian version of the Expanded Prostate Cancer Index Composite (EPIC) for patients submitted to radical prostatectomy.
Alves E; Medina R; Andreoni C
Int Braz J Urol; 2013; 39(3):344-52. PubMed ID: 23849583
[TBL] [Abstract][Full Text] [Related]
14. Psychometric testing of the Norwegian version of the Expanded Prostate Cancer Index Composite 26-item version (EPIC-26).
Fosså SD; Storås AH; Steinsvik EA; Myklebust TA; Eri LM; Loge JH; Dahl AA
Scand J Urol; 2016 Aug; 50(4):280-5. PubMed ID: 27049891
[TBL] [Abstract][Full Text] [Related]
15. Portuguese version of the Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP): psychometric validation and prospective application for early functional outcomes at a single institution.
Lourenço DB; Amaral BS; Alfer-Junior W; Vasconcellos A; Russo F; Sanchez-Salas R; Bianco B; Wagner AA; Chang P; Moschovas MC; Lemos GC; Carneiro A
BMC Urol; 2020 Oct; 20(1):163. PubMed ID: 33081748
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of the korean version of expanded prostate cancer index composite: questionnaire assessing health-related quality of life after prostate cancer treatment.
Chung KJ; Kim JJ; Lim SH; Kim TH; Han DH; Lee SW
Korean J Urol; 2010 Sep; 51(9):601-12. PubMed ID: 20856644
[TBL] [Abstract][Full Text] [Related]
17. Living alone, obesity and smoking: important factors for quality of life after radiotherapy and androgen deprivation therapy for prostate cancer.
Dieperink KB; Hansen S; Wagner L; Johansen C; Andersen KK; Hansen O
Acta Oncol; 2012 Jul; 51(6):722-9. PubMed ID: 22793038
[TBL] [Abstract][Full Text] [Related]
18. Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up.
Ferrer M; Guedea F; Suárez JF; de Paula B; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Boladeras A; Ayala A; Craven-Bratle J; Ávila M; Cunillera O; Pardo Y; Alonso J; Aguiló F;
Radiother Oncol; 2013 Aug; 108(2):306-13. PubMed ID: 23849168
[TBL] [Abstract][Full Text] [Related]
19. Early postoperative urinary and sexual function predicts functional recovery 1 year after prostatectomy.
Ellison JS; He C; Wood DP
J Urol; 2013 Oct; 190(4):1233-8. PubMed ID: 23608677
[TBL] [Abstract][Full Text] [Related]
20. Validation of the French-Canadian version of the Expanded Prostate Cancer Index Composite (EPIC) in a French-Canadian population.
Vigneault É; Savard J; Savard MH; Ivers H; Després P; Foster W; Martin AG; Fradet V
Can Urol Assoc J; 2017 Dec; 11(12):404-410. PubMed ID: 29106365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
